Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.360
-0.050 (-2.07%)
Jul 17, 2026, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 437.83 million as of July 17, 2026. Its market cap has decreased by -20.67% in one year.
Market Cap
437.83M
Enterprise Value
730.28M
Revenue
737.49M
Ranking
n/a
PE Ratio
16.74
Stock Price
2.36
ChartMarket Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 437.83M, a decrease of -36.57%. That is a compound annual growth rate of -8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 437.83M | -16.60% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 10.61B |
| Integral Diagnostics | 782.23M |
| Healius | 283.20M |
| Monash IVF Group | 274.69M |
| Cryosite | 63.45M |
| Rhythm Biosciences | 30.43M |
| INOVIQ | 28.16M |
| BCAL Diagnostics | 28.02M |